An update on ex vivo lung perfusion in pulmonary transplantation

被引：0
作者：
Lin J. [1 ]
机构：
[1] Section of Thoracic Surgery, Department of Surgery, University of Michigan Medical Center, 1500 E. Medical Center Drive, 2120TC/5344, Ann Arbor, 48109-5344, MI
来源：
Current Surgery Reports | / 5卷 / 3期
关键词：
Donor lung procurement; Ex vivo lung perfusion EVLP; Lung preservation; Lung transplantation;
D O I：
10.1007/s40137-017-0171-8
中图分类号：
学科分类号：
摘要：
Purpose of Review Lung transplantation provides quality of life and survival benefits for patients with end-stage lung disease. However, the demand for donor lungs continues to exceed the supply. Using standard selection criteria, only 20% of lungs from solid organ donors are currently used for lung transplant. Ex vivo lung perfusion may provide a means to evaluate and to potentially rehabilitate marginal donor lungs prior to transplantation. Recent Findings Outcomes after transplantation of marginal lungs evaluated using ex vivo lung perfusion, after initially being declined using standard criteria, have been reported to be equivalent in several studies to outcomes after transplant using standard donor lungs. Ex vivo lung perfusion has also been used successfully in the evaluation of lungs in donation after cardiac death donors, another potential source for increasing the donor pool. Summary This review provides an update on recent experience and results of transplantation after ex vivo lung perfusion, ongoing clinical trials, as well as future directions and ways ex vivo lung perfusion, may increase the availability of donor lungs. © Springer Science + Business Media New York 2017.
引用
收藏
相关论文
共 61 条
[1]  
Valapour M., Skeans M.A., Smith J.M., Et al., Optn/srtr 2015 annual data report: Lung, Am J Transplant, 17, pp. 357-424, (2017)
[2]  
Valapour M., Skeans M.A., Heubner B.M., Et al., Optn/srtr 2013 annual data report: Lung, Am J Transplant, 15, pp. 1-28, (2015)
[3]  
Israni A.K., Zaun D., Bolch C., Et al., Optn/srtr 2015 annual data report: Deceased organ donation, Am J Transplant, 17, pp. 503-542, (2017)
[4]  
Orens J.B., Boehler A., de Perrot M., Et al., A review of lung transplant donor acceptability criteria, J Heart Lung Transplant, 22, 11, pp. 1183-1200, (2003)
[5]  
Meyers B.F., Lynch J., Trulock E.P., Guthrie T.J., Cooper J.D., Patterson G.A., Lung transplantation: A decade of experience, Ann Surg, 230, 3, pp. 362-370, (1999)
[6]  
Merlo C., Orens J., Selection of candidates for lung transplanta-tion, Curr Opin Organ Transpl., 12, pp. 749-784, (2007)
[7]  
Thabut G., Mal H., Cerrina J., Et al., Graft ischemic time and outcome of lung transplantation: A multicenter analysis, Am J Respir Crit Care Med, 171, 7, pp. 786-791, (2005)
[8]  
de Perrot M., Keshavjee S., Lung preservation, Semin Thorac Cardiovasc Surg, 16, 4, pp. 300-308, (2004)
[9]  
Southard J.H., Belzer F.O., Organ preservation, Annu Rev Med, 46, pp. 235-247, (1995)
[10]  
Venuta F., Rendina E.A., Bufi M., Et al., Preimplantation retrograde pneumoplegia in clinical lung transplantation, J. Thorac Cardio-Vasc Surg., 118, 1, pp. 107-114, (1999)
1234567